Abstract
Improved model systems to predict drug efficacy, interactions, and drug-induced kidney injury (DIKI) are crucially needed in drug development. Organ-on-a-chip technology is a suitable in vitro system because it reproduces the 3D microenvironment. A kidney-on-a-chip can mimic the structural, mechanical, transport, absorptive, and physiological properties of the human kidney. In this review we address the application of state-of-the-art microfluidic culturing techniques, with a focus on culturing kidney proximal tubules, that are promising for the detection of biomarkers that predict drug interactions and DIKI. We also discuss high-throughput screening and the challenges for in vitro to in vivo extrapolation (IVIVE) that will need to be overcome for successful implementation.
Original language | English |
---|---|
Pages (from-to) | 156-170 |
Number of pages | 15 |
Journal | Trends in Biotechnology |
Volume | 34 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2016 |
Keywords
- organ-on-a-chip
- nephrotoxicity
- drug screening
- microfluidics
- high-throughput screening
- kidney